Revvity serves the pharmaceutical and biotech industries, diagnostic labs, academia. and governments in more than 160 ...

Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.

Researchers say study underscores how psychedelics may help dial down inflammation and reset brain-immune interactions.

"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...

The team tested the impact on eight novel helper plasmids with different deletions in the E2 and E4 genes on four rAAV serotypes. They discovered that some deletions affected productivity, reducing ...

One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.

Revvity and Watchmaker Genomics are working to bring more flexible and scalable NGS solutions to researchers worldwide.

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

These insights from researchers could have major implications for diseases like cancer, where gene expression goes awry.

"Phosphorylation is a key mechanism for regulating protein activity and signaling pathways across the entire range of ...

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...